Mammography Devices Market Report 2024

This Mammography Devices market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The mammography devices market size has grown rapidly in recent years. It will grow from $1.77 billion in 2023 to $1.97 billion in 2024 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to increased government initiatives, a growing number of elderly women, expanded healthcare facilities and access, improvements in insurance and reimbursement policies, and the rising aging population.

The mammography devices market size is expected to see rapid growth in the next few years. It will grow to $3.07 billion in 2028 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to the increasing incidence of breast cancer, a higher demand for early-stage diagnosis, a growing need for portable mammography systems, greater adoption of digital tools in healthcare diagnostics, and rising research and development in healthcare. Major trends include the development of AI-powered mammography devices, advancements in digital mammography, improvements in 3D breast tissue reconstruction technology, progress in automated breast ultrasound (ABUS), and innovations in breast biopsy techniques.

The rising prevalence of breast cancer is anticipated to drive the growth of the mammography device market in the coming years. Breast cancer involves the abnormal proliferation of cells in breast tissue, potentially forming malignant tumors that may spread to other parts of the body. Contributing factors to the increasing incidence of breast cancer include lifestyle changes, an aging population, inherited genetic mutations, and hormonal influences. Mammography devices are essential for combating breast cancer as they facilitate early detection, accurate diagnosis, and effective management, ultimately enhancing patient outcomes and survival rates. For example, in January 2024, the American Cancer Society, a US-based nonprofit organization, projected that approximately 310,720 new cases of invasive breast cancer would be diagnosed in women in 2024. Additionally, about 42,250 women are expected to die from breast cancer this year. The incidence rates have been increasing by 0.6% annually, with a slightly higher increase of 1% per year in women under 50. Consequently, the growing prevalence of breast cancer is fueling the expansion of the mammography device market.

Key players in the mammography devices market are concentrating on developing advanced technologies, such as mammography systems with wide-angle tomosynthesis, to enhance image resolution and clarity. Wide-angle tomosynthesis represents a sophisticated breast imaging technology that improves upon traditional mammography by providing three-dimensional (3D) images of breast tissue. This technology is particularly effective in detecting breast cancer in dense tissue, where overlapping structures may obscure abnormalities in standard 2D mammography. For instance, in September 2023, Siemens Healthineers, a Germany-based medical technology company, introduced the Mammomat B. Brilliant mammography system featuring wide-angle tomosynthesis. The Mammomat B. Brilliant incorporates the innovative PlatinumTomo technology with a 50° tube movement, the widest angle available. This system offers a rapid scan time of approximately five seconds, making it the fastest in its class and enabling high-definition 3D imaging. It provides exceptional accuracy in identifying abnormalities and microcalcifications, with an acquisition speed approximately 35% faster than other models. The device also introduces Flying Focus Spot technology, a first in mammography, which reduces blurring effects from tube movement, ensuring sharp images even at high speeds.

In November 2022, Teledyne DALSA, a Canada-based manufacturer of specialized electronic imaging components, acquired Sigmascreening B.V. for an undisclosed amount. This acquisition provides Teledyne DALSA with exclusive access to Sigmascreening’s intellectual property portfolio related to breast mammography and algorithms, including innovative biomechanical characteristics and pressure-sensitive breast compression technology. Sigmascreening B.V. is a Netherlands-based company specializing in mammographic technology.

Major companies operating in the mammography devices market are Siemens Healthineers AG, Fujifilm Holdings Corporation, Becton, Dickinson and Company, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Konica Minolta Inc., Hologic Inc., Carestream Health Inc., Analogic Corporation, Canon Medical Systems Corporation, Aurora Health Care Inc., DMS Group, SuperSonic Imagine Ltd., Villa Sistemi Medicali S.p.A, Planmed Oy, Allengers Medical Systems Limited, General Medical Merate S.p.A, KUB Technologies Inc., Delphinus Medical Technologies Inc., Metaltronica S.p.A., SonoCiné Inc., Micrima Limited, IMS Giotto S.p.A., CMR Naviscan Corporation, SternMed GmbH.

North America was the largest region in the mammography devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mammography devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the mammography devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Mammography devices are specialized imaging systems used to produce detailed images of breast tissue, primarily for the early detection and diagnosis of breast cancer. These devices play a crucial role in breast cancer screening and diagnosis, significantly aiding in early detection and treatment.

The main types of mammography devices include analog, digital, and others. An analog mammography device employs X-ray technology to capture and display images of the breast on film or digital media to identify abnormalities or breast cancer. These devices can be portable or non-portable and are used by hospitals, specialty clinics, and diagnostic centers.

The mammography devices market research report is one of a series of new reports that provides mammography devices market statistics, including mammography devices industry global market size, regional shares, competitors with a mammography devices market share, detailed mammography devices market segments, market trends and opportunities, and any further data you may need to thrive in the mammography devices industry. This mammography devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mammography devices market consists of sales of digital breast tomosynthesis (DBT) systems, breast ultrasound systems, mammography biopsy systems and mammography accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.